| Authors: |
Diamanti K; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden., Visvanathar R; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden., Pereira MJ; Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden., Cavalli M; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Pan G; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Kumar C; Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Karolinska Institute/AstraZeneca Integrated CardioMetabolic Centre (KI/AZ ICMC), Department of Medicine, Novum, Huddinge, Sweden., Skrtic S; Pharmaceutical Technology & Development, AstraZeneca AB, Gothenburg, Sweden.; Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Risérus U; Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden., Eriksson JW; Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden., Kullberg J; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden.; Antaros Medical AB, Mölndal, Sweden., Komorowski J; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.; Institute of Computer Science, PAN, Warsaw, Poland., Wadelius C; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Ahlström H; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden. hakan.ahlstrom@radiol.uu.se.; Antaros Medical AB, Mölndal, Sweden. hakan.ahlstrom@radiol.uu.se. |
